{"issuance_frequency":"","notes_translated":{"fr":"\"Au Canada, les installations où sont manipulés ou entreposés des agents pathogènes humains ou des toxines du groupe de risque 2 (GR2), GR3 et GR4 sont réglementés par l'Agence de la santé publique du Canada (ASPC) en vertu de la Loi sur les agents pathogènes humains et les toxines (LAPHT) et du Règlement sur les agents pathogènes humains et les toxines (RAPHT). l'importation d'agents zoopathogènes, d'animaux infectés, des produits ou sous-produits animaux (p. ex. tissus, sérum) ou d'autres substances pouvant contenir un agent pathogène ou une partie de celui-ci (p. ex. toxine) est réglementée par l'ASPC ou l'Agence canadienne d'inspection des aliments (ACIA) en vertu de la Loi sur la santé des animaux (LSA) et du Règlement sur la santé des animaux (RSA).\r\n\r\nUn virus influenza A qui est un agent pathogène nouveau ou émergent est souvent considéré comme étant un agent pathogène humain du GR3 par l'ASPC et un agent zoopathogène du GR3 par l'ACIA. Cette Directive en matière de biosécurité a été élaborée par l'ASPC et l'ACIA pour aider les établissements à déterminer le niveau de confinement approprié et les exigences additionnelles en matière de biosécurité pour la manipulation sécuritaire des échantillons soupçonnés ou confirmés de contenir une souche de virus de la grippe A (ou virus influenza A) nouvelle ou émergente. Les installations tels que les laboratoires de diagnostic et de recherche peuvent utiliser la présente directive pour mettre en œuvre des exigences physiques et des pratiques opérationnelles appropriées lors de la manipulation d'échantillons contenant des souches ou des sous-types de virus influenza A nouveaux ou émergents. Des informations générales sur le virus influenza A, y compris les souches en circulation du virus influenza A (c.-à-d. qui ne sont pas nouvelles ou émergentes), sont également incluses. La Directive en matière de biosécurité portant sur les virus de la grippe (influenza) A nouveaux et émergents doit être consultée en parallèle avec la Norme canadienne sur la biosécurité (NCB).\"\r\n","en":"\"In Canada, facilities that handle or store Risk Group 2 (RG2), RG3, and RG4 human pathogens or toxins are regulated by the Public Health Agency of Canada (PHAC) under the Human Pathogens and Toxins Act (HPTA) and the Human Pathogens and Toxins Regulations (HPTR). The importation of animal pathogens, infected animals, animal products or by-products (e.g., tissue, serum), or other substances that may carry an animal pathogen or a part of one (e.g., toxin) are regulated by the PHAC or the Canadian Food Inspection Agency (CFIA) under the Health of Animals Act (HAA) and Health of Animals Regulations (HAR). In Canada, facilities that handle or store Risk Group 2 (RG2), RG3, and RG4 human pathogens or toxins are regulated by the Public Health Agency of Canada (PHAC) under the Human Pathogens and Toxins Act (HPTA) and the Human Pathogens and Toxins Regulations (HPTR). The importation of animal pathogens, infected animals, animal products or by-products (e.g., tissue, serum), or other substances that may carry an animal pathogen or a part of one (e.g., toxin) are regulated by the PHAC or the Canadian Food Inspection Agency (CFIA) under the Health of Animals Act (HAA) and Health of Animals Regulations (HAR).\r\n\r\nAn Influenza A virus that is a new or emerging pathogen is often classified as an RG3 human pathogen by the PHAC and RG3 animal pathogen by the CFIA. This Biosafety Directive has been developed by the PHAC and the CFIA to assist facilities in determining the appropriate containment level and additional biosafety requirements for the safe handling of samples that are suspected of or confirmed to contain a new or emerging strain of influenza A virus. Facilities such as diagnostic and research laboratories may use this Directive to implement the appropriate physical requirements and operational practices when handling samples containing new or emerging subtypes or strains of influenza A virus. General information on influenza A virus, including circulating strains of influenza virus (i.e., not new or emerging), is also included. The Biosafety Directive for New and Emerging Influenza A Viruses is to be used in conjunction with the Canadian Biosafety Standard (CBS).\"\r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"48af4e64-a2d5-4c79-8374-ce5bf34caa81","metadata_created":"2019-02-11T20:52:35.128405","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2019-02-11T20:52:35.128423","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2019-02-11","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Risques","analyse","évaluation","hypothèses","agent pathogène","évaluation des risques","ligne directrice","fondée sur des données probantes","quantitative","qualitative","risque","canadien","biosécurité","agents pathogènes","public","santé","agence","Canada","groupe de risque","virus","influenza A","locale","niveau de confinement","souches génétiquement crées ou modifiées","exigences internationales","exigences opérationnelles","supplémentaires"],"en":["Risk","analysis","assessment","Pathogen","Risk Assessment","guideline","Evidence-based","quantitative","qualitative","hazard","Canadian","Biosafety","Guideline","requirements","Pathogen","Public","Health","Agency","Canada","risk group","influenza A","viruses","local","containment","level","genetically engineered strains","International containment level requirements","operational requirements"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Directive en matière de biosécurité portant sur les virus de la grippe (influenza) A nouveaux et émergents","en":"Biosafety Directive for New and Emerging Influenza A Viruses"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"48af4e64-a2d5-4c79-8374-ce5bf34caa81","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"933448e6-dc85-4f07-96e3-2b70d18612c4","related_relationship":"","name_translated":{"fr":"Directive en matière de biosécurité portant sur les virus de la grippe (influenza) A nouveaux et émergents","en":"Biosafety Directive for New and Emerging Influenza A Viruses"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Biosafety Directive for New and Emerging Influenza A Viruses","language":["en"],"created":"2019-02-11T20:52:35.842462","url":"https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/biosafety-directives-advisories-notifications/new-emerging-influenza-a-viruses.html","last_modified":null,"position":0,"revision_id":"ef80eb08-1eb4-4855-9e76-46179891e129","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"48af4e64-a2d5-4c79-8374-ce5bf34caa81","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"de5ed7df-f864-4f1a-b14e-86be6b3b433f","related_relationship":"","name_translated":{"fr":"Directive en matière de biosécurité portant sur les virus de la grippe (influenza) A nouveaux et émergents","en":"Biosafety Directive for New and Emerging Influenza A Viruses"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Biosafety Directive for New and Emerging Influenza A Viruses","language":["fr"],"created":"2019-02-11T20:52:35.842469","url":"https://www.canada.ca/fr/sante-publique/services/biosecurite-biosurete-laboratoire/directives-avis-avis-speciaux-matiere-biosecurite/virus-grippe-influenza-a-nouveaux-emergents.html","last_modified":null,"position":1,"revision_id":"ef80eb08-1eb4-4855-9e76-46179891e129","resource_type":"website"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2018-10-01 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"48af4e64-a2d5-4c79-8374-ce5bf34caa81","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"\"In Canada, facilities that handle or store Risk Group 2 (RG2), RG3, and RG4 human pathogens or toxins are regulated by the Public Health Agency of Canada (PHAC) under the Human Pathogens and Toxins Act (HPTA) and the Human Pathogens and Toxins Regulations (HPTR). The importation of animal pathogens, infected animals, animal products or by-products (e.g., tissue, serum), or other substances that may carry an animal pathogen or a part of one (e.g., toxin) are regulated by the PHAC or the Canadian Food Inspection Agency (CFIA) under the Health of Animals Act (HAA) and Health of Animals Regulations (HAR). In Canada, facilities that handle or store Risk Group 2 (RG2), RG3, and RG4 human pathogens or toxins are regulated by the Public Health Agency of Canada (PHAC) under the Human Pathogens and Toxins Act (HPTA) and the Human Pathogens and Toxins Regulations (HPTR). The importation of animal pathogens, infected animals, animal products or by-products (e.g., tissue, serum), or other substances that may carry an animal pathogen or a part of one (e.g., toxin) are regulated by the PHAC or the Canadian Food Inspection Agency (CFIA) under the Health of Animals Act (HAA) and Health of Animals Regulations (HAR).\r\n\r\nAn Influenza A virus that is a new or emerging pathogen is often classified as an RG3 human pathogen by the PHAC and RG3 animal pathogen by the CFIA. This Biosafety Directive has been developed by the PHAC and the CFIA to assist facilities in determining the appropriate containment level and additional biosafety requirements for the safe handling of samples that are suspected of or confirmed to contain a new or emerging strain of influenza A virus. Facilities such as diagnostic and research laboratories may use this Directive to implement the appropriate physical requirements and operational practices when handling samples containing new or emerging subtypes or strains of influenza A virus. General information on influenza A virus, including circulating strains of influenza virus (i.e., not new or emerging), is also included. The Biosafety Directive for New and Emerging Influenza A Viruses is to be used in conjunction with the Canadian Biosafety Standard (CBS).\"\r\n","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Biosafety Directive for New and Emerging Influenza A Viruses","revision_id":"ef80eb08-1eb4-4855-9e76-46179891e129"}